Fortis Memorial Research Institute

A standardized clinical algorithm for patient selection in cellular therapy across nineteen solid and hematological malignancies: An algorithm development study

ABSTRACT Background: Cellular therapies—chimeric antigen receptor T-cell (CAR-T), tumor-infiltrating lymphocyte (TIL), T-cell receptor (TCR)-engineered, gamma-delta (γδ) T-cell, and high-dose interleukin-2—have transformed the management of refractory malignancies. Over 6,000 int...